NCT07237438 TIVA Versus Balanced Anesthesia on Muscle Mass in CRC Surgery
| NCT ID | NCT07237438 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Grigore T. Popa University of Medicine and Pharmacy |
| Condition | Colorectal Cancer (CRC) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-09-20 |
| Primary Completion | 2026-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-09-20 with a primary completion date of 2026-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is aimed at clarifying changes in body composition during the perioperative period and identifying risk factors for skeletal muscle mass loss in patients with colorectal cancer. The investigators will asess the impact of the type of anaesthesia (total intravenous anaesthesia/sevoflurane anaesthesia) for colorectal surgery on the muscle function and mass, which will be evaluated using ultrasound, dynamometry and bioimpedance.
Eligibility Criteria
Inclusion Criteria: • adult patients diagnosed with colorectal cancer and scheduled for open colorectal surgery at the Regional Institute of Oncology, Iaşi, Romania Exclusion Criteria: * lack the capacity to consent * extremity amputation * paraplegia * diseases affecting the muscles (such as stroke, lower-limb immobilization from a plaster, neurodegenerative diseases, peripheral neuropathy or muscle dystrophy) * terminal cancer
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07237438 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer (CRC). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07237438 currently recruiting?
Yes, NCT07237438 is actively recruiting participants. Contact the research team at ianis.siriopol@gmail.com for enrollment information.
Where is the NCT07237438 trial being conducted?
This trial is being conducted at Iași, Romania.
Who is sponsoring the NCT07237438 clinical trial?
NCT07237438 is sponsored by Grigore T. Popa University of Medicine and Pharmacy. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.